Screener
Cytokinetics CYTK Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's long-term debt?
- Cytokinetics (CYTK) reported long-term debt of $248.2M in Q2 2026.
- How has Cytokinetics's long-term debt changed year-over-year?
- Cytokinetics's long-term debt increased by 56.0% year-over-year, from $159.06M to $248.2M.
- What is the long-term trend for Cytokinetics's long-term debt?
- Over 5 years (2020 to 2025), Cytokinetics's long-term debt has grown at a 39.8% compound annual growth rate (CAGR), from $46.21M to $246.38M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Cytokinetics's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude